The Lobster Pot was boiling last Wednesday at the Women in Bio and Johnson & Johnson Innovation Shark Tank-style pitch event in Cambridge, MA. Organized by the LSN team, eight female life science CEOs gave 6-minute pitches proceeded by short sessions of feedback from five female investors.

So how hot did the "chef" investors boil these "lobster" CEOs? Below are common critiques to fundraising entrepreneurs - be sure to take these into account for your next presentation.

Keep in mind who your audience is and tailor your message appropriately. Take into account their background and expertise...

The diagnostics space encompasses a very wide range of technologies targeting indications across the board, and is arguably the most difficult sector, under the life science umbrella, to successfully navigate. Not only do these entrepreneurs have to first identify the correct capital providers and strategic partners to make their technologies a commercial reality, like everyone else, but piquing the interests of those entities may be considerably more difficult. Oftentimes, clearly articulating the value proposition of your diagnostic product/service is a little trickier than that of a more traditional therapeutic or medical device, and the go-to-market strategy for these technologies will usually be more highly scrutinized.

Moderated by John Walter, CEO & President, Alliance for Cancer Gene Therapy Foundation, this session will feature: